US regulator approves limited use of malaria drugs for virus

A limited emergency-use authorization for two antimalarial drugs touted as game-changers by US President Donald Trump has been issued by the US Food and Drug Administration to treat coronavirus patients.

In a statement published yesterday, the US Department of Health and Human Services details recent donations of medicine to a national stockpile — including chloroquine and hydroxychloroquine, both being investigated as potential COVID-19 treatments.

It says the FDA had allowed them “to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.”

— AFP

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.